# Tang Dynasty Reishi (Ganoderma lucidum 'Tang Dynasty')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/tang-dynasty-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma lucidum 'Tang Dynasty', Tang Dynasty Lingzhi, Historical Reishi Strain, Tang Period Ganoderma, Imperial Reishi Variety, Tang Era Lingzhi, Ancient Chinese Reishi, Traditional Tang Mushroom

## Overview

Tang Dynasty Reishi is a cultivated strain of Ganoderma lucidum selectively propagated for enhanced polysaccharide yield, producing approximately 3.5 g/L exopolysaccharides (EPS) under optimized fermentation conditions. Its primary bioactive compounds — [beta-glucan](/ingredients/condition/immune-support)s and triterpenoids — are theorized to modulate immune signaling via Toll-like receptor 2 and 4 activation, though no clinical trials have validated strain-specific therapeutic outcomes.

## Health Benefits

• No clinical evidence available - research focuses solely on cultivation techniques
• Traditional use suggests [longevity](/ingredients/condition/longevity) support - no modern clinical validation found
• Historical [adaptogen](/ingredients/condition/stress)ic properties claimed - lacks contemporary scientific verification
• Polysaccharide content (EPS 3.5 g/L, IPS 4.8 g/L) from general G. lucidum cultivation - no strain-specific or health outcome data
• Traditional ranking as 'superior adaptogen' in TCM - no clinical trials support efficacy

## Mechanism of Action

The [beta-glucan](/ingredients/condition/immune-support) polysaccharides in Ganoderma lucidum strains bind to Dectin-1 receptors and Toll-like receptors (TLR2/TLR4) on macrophages and dendritic cells, triggering NF-κB signaling pathways that upregulate [cytokine](/ingredients/condition/inflammation) production including TNF-α and IL-6. Triterpene acids such as ganoderic acid A inhibit 5-alpha reductase and HMG-CoA reductase activity in preclinical models. For this specific Tang Dynasty cultivar, these mechanisms remain extrapolated from general G. lucidum research, as no strain-specific receptor binding or enzyme inhibition studies have been published.

## Clinical Summary

No clinical trials have been conducted specifically on the Tang Dynasty cultivar of Ganoderma lucidum; all available evidence is limited to fermentation and cultivation optimization studies focusing on EPS yield. General Ganoderma lucidum research includes small randomized controlled trials — typically 30 to 100 participants — examining [immune modulation](/ingredients/condition/immune-support), [fatigue reduction](/ingredients/condition/energy) in cancer patients, and [blood glucose](/ingredients/condition/weight-management) regulation, but these cannot be directly extrapolated to this strain. A 2006 RCT by Gao et al. in 34 advanced-stage cancer patients showed improved natural killer cell activity with standardized G. lucidum polysaccharide extract, representing the broader evidence base. Overall, evidence quality for Tang Dynasty Reishi specifically is rated negligible, and benefit claims for this strain remain unsupported by direct human data.

## Nutritional Profile

Tang Dynasty Reishi (Ganoderma lucidum 'Tang Dynasty') is a cultivated strain of G. lucidum with nutritional and bioactive characteristics broadly consistent with the species, though strain-specific analytical data is limited. Based on general G. lucidum compositional literature and the limited cultivation data available for this strain: **Macronutrients (per 100 g dry weight, approximate):** • Protein: 7–18 g (containing all essential amino acids; glutamic acid and aspartic acid predominate) • Total carbohydrates: 24–48 g (largely comprised of polysaccharides including β-glucans and heteropolysaccharides) • Crude fat: 3–5 g (includes fatty acids such as oleic and linoleic acid) • Dietary fiber: 25–45 g (predominantly chitin and β-glucan-based cell wall polysaccharides) • Moisture (dried fruiting body): 8–12% **Key Bioactive Compounds:** • β-Glucans (1,3/1,6-β-D-glucans): estimated 25–45% of dry weight polysaccharide fraction; primary [immunomodulatory](/ingredients/condition/immune-support) compounds; oral bioavailability is limited due to high molecular weight but partial absorption occurs via Peyer's patches and gut-associated lymphoid tissue • Ganoderic acids (triterpenoids): typically 1–5% of dry weight in G. lucidum fruiting bodies; over 150 types reported in the species (ganoderic acids A, B, C, D, F among most studied); bitter-tasting, lipophilic compounds with low oral bioavailability unless formulated with lipid carriers • Exopolysaccharides (EPS): 3.5 g/L reported in submerged culture of this strain • Intracellular polysaccharides (IPS): 4.8 g/L reported in submerged culture of this strain • Ergosterol (provitamin D₂): ~0.3–0.6% dry weight; convertible to vitamin D₂ upon UV-B exposure • Adenosine and related nucleosides: trace amounts (~0.05–0.1% dry weight) **Minerals (per 100 g dry weight, approximate from G. lucidum species data):** • Potassium: 200–600 mg • Phosphorus: 100–300 mg • Calcium: 30–80 mg • Magnesium: 20–60 mg • Zinc: 3–8 mg • Selenium: 1–7 µg (highly dependent on substrate composition) • Iron: 2–10 mg • Germanium: trace organic germanium reported in some G. lucidum strains (0.01–0.05%) **Vitamins:** • B-complex vitamins present in modest amounts: niacin (B3) ~3–5 mg/100 g, riboflavin (B2) ~1–2 mg/100 g, thiamine (B1) ~0.1–0.3 mg/100 g • Vitamin D₂: negligible unless UV-treated (potential to reach 10–100 µg/100 g post-UV exposure) • No significant vitamin C or fat-soluble vitamins (A, E, K) **Bioavailability Notes:** • Triterpenoids (ganoderic acids) are poorly water-soluble; dual extraction (hot water + ethanol) significantly increases recovery; bioavailability enhanced by lipid co-administration • β-Glucan bioavailability is inherently low orally but immunological activity may occur through gut immune receptor activation (Dectin-1, CR3) rather than systemic absorption • Chitin-bound nutrients require thorough extraction or cooking to liberate; raw fruiting body consumption yields poor nutrient availability • No strain-specific ('Tang Dynasty') bioavailability or pharmacokinetic studies have been published; all values are extrapolated from general G. lucidum species literature and should be interpreted with caution

## Dosage & Preparation

No clinically studied dosage ranges are reported for Tang Dynasty Reishi in any form (extract, powder, or standardized). Research emphasizes cultivation yields (25% biological efficiency) rather than human dosing parameters. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

General Ganoderma lucidum preparations are associated with mild gastrointestinal side effects including nausea, dry mouth, and loose stools, particularly at doses exceeding 1.5 g/day of concentrated extract. Significant drug interactions are documented with anticoagulants such as warfarin, as G. lucidum triterpenoids exhibit platelet aggregation inhibition and may potentiate bleeding risk. Immunosuppressant medications including tacrolimus and cyclosporine may have altered efficacy due to the immunostimulatory activity of [beta-glucan](/ingredients/condition/immune-support) fractions. Pregnancy and lactation safety has not been established for any Ganoderma lucidum strain, including Tang Dynasty Reishi, and use is not recommended in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found for Tang Dynasty Reishi or general G. lucidum strains in the available research. The literature exclusively focuses on cultivation techniques and yield optimization rather than clinical efficacy or health outcomes. No PubMed PMIDs are available for clinical studies.

## Historical & Cultural Context

Ganoderma lucidum, including strains evoking historical varieties like those from the Tang Dynasty, has been used in Traditional Chinese Medicine as a superior [adaptogen](/ingredients/condition/stress) and 'mushroom of immortality' for over 2,000 years. It was historically cultivated on logs or substrates in China, Japan, and elsewhere, with references to its elite status in ancient texts and ranked at the top of herbal classics for promoting [longevity](/ingredients/condition/longevity), vitality, and health.

## Synergistic Combinations

Other Reishi variants, Cordyceps, Turkey Tail, Lion's Mane, Astragalus

## Frequently Asked Questions

### What makes Tang Dynasty Reishi different from regular Ganoderma lucidum?

Tang Dynasty Reishi is a selectively cultivated strain optimized for elevated exopolysaccharide (EPS) production, yielding approximately 3.5 g/L under specific submerged fermentation conditions compared to lower outputs in wild-type strains. The distinction is primarily agronomic and biochemical rather than clinically validated, meaning its therapeutic profile has not been studied in human trials separate from standard G. lucidum research.

### Does Tang Dynasty Reishi have any clinical trials supporting its benefits?

As of current literature, no published clinical trials exist specifically investigating Tang Dynasty Reishi in human subjects; available research is confined to cultivation methodology and polysaccharide yield optimization. Any health benefit claims for this strain are extrapolated from broader Ganoderma lucidum research, which itself is characterized by small sample sizes and variable standardization.

### What is the polysaccharide content of Tang Dynasty Reishi?

Tang Dynasty Reishi has been documented to produce approximately 3.5 g/L of exopolysaccharides (EPS) under optimized fermentation conditions; intracellular polysaccharide (IPS) data appears incomplete in available sourcing. These polysaccharides are primarily beta-1,3/1,6-glucans, which in other G. lucidum strains are associated with immunomodulatory activity via Dectin-1 receptor binding.

### Can Tang Dynasty Reishi interact with blood thinners like warfarin?

Based on established interactions for Ganoderma lucidum broadly, Tang Dynasty Reishi should be used with caution alongside anticoagulants such as warfarin or heparin, as triterpene compounds in G. lucidum inhibit platelet aggregation and may elevate bleeding risk. Patients on anticoagulant therapy should consult a physician before use, as no strain-specific interaction studies exist to determine whether Tang Dynasty Reishi's specific triterpene profile amplifies or reduces this risk.

### What is the traditional use of Tang Dynasty Reishi for longevity?

In Traditional Chinese Medicine, Ganoderma lucidum — referred to as Lingzhi — has been documented for over 2,000 years as a tonic for Shen (spirit), immune vitality, and longevity, appearing in texts such as the Shennong Bencao Jing. The Tang Dynasty designation likely reflects historical cultivation or reverence during the Tang period (618–907 CE), though modern clinical science has not validated longevity-specific outcomes for this or any other G. lucidum cultivar.

### Is Tang Dynasty Reishi safe for pregnant women or breastfeeding mothers?

Tang Dynasty Reishi has not been formally studied in pregnant or breastfeeding populations, and safety data specific to this cultivar variant is unavailable. Due to its bioactive polysaccharide content and traditional use as an adaptogen, it is generally recommended that pregnant and nursing women consult a healthcare provider before use. Standard caution applies, as Ganoderma lucidum may have mild anticoagulant properties that could be relevant during pregnancy.

### What is the recommended daily dosage for Tang Dynasty Reishi, and when should I take it?

No official dosage recommendations exist specifically for Tang Dynasty Reishi, as clinical trials are absent. Traditional use and general Ganoderma lucidum supplementation typically range from 1–3 grams daily in divided doses, though individual tolerability varies. Many users take reishi in the evening or before bed due to its traditional reputation for promoting relaxation and sleep quality, but timing should be individualized based on personal response.

### How does Tang Dynasty Reishi compare to wild-harvested or other cultivated Ganoderma lucidum varieties?

Tang Dynasty Reishi is a cultivated variant bred using documented cultivation techniques; while it shares the same species classification as wild and other cultivated forms, direct comparative data on efficacy or bioactive potency is unavailable. The strain is marketed as distinct from standard varieties, but no published studies directly benchmark its polysaccharide bioavailability or physiological effects against other Ganoderma lucidum strains. Differences likely exist in cultivation conditions and resulting metabolite profiles, but claims of superiority remain unvalidated by clinical research.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*